Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

doi:10.1084/jem.160.1.310

This Article

	Full Text (PDF, 431K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Huber, C.
	Articles by Wachter, H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Huber, C.
	Articles by Wachter, H.


Social Bookmarking

	What's this?

ARTICLES

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

C Huber, JR Batchelor, D Fuchs, A Hausen, A Lang, D Niederwieser, G Reibnegger, P Swetly, J Troppmair and H Wachter

Neopterin, a compound derived from GTP, represents a precursor molecule of biopterin that is an essential cofactor in neurotransmitter synthesis. We have recently reported that in vivo as well as in vitro immune responses are accompanied by an increased release of neopterin and that this phenomenon can be used for the biochemical monitoring of diseases accompanied by hyperimmune stimulation. This article deals with the cellular origin and the control of this immune response- associated neopterin release in vitro. Using highly purified or monoclonal cellular reagents we demonstrate that macrophages (M phi) stimulated with supernatants from activated T cells release large amounts of neopterin into culture supernatants. Further experiments involving induction of neopterin release from M phi with various human recombinant interferons (IFNs) or neutralization of the effect of T cell supernatants with various monoclonal anti-IFN antibodies revealed immune IFN as the active principle. It thus appears that a metabolic pathway so far exclusively known in context with the generation of an essential cofactor of neurotransmitter-synthesis during immune responses is also activated in M phi under stringent control by immune IFN-like lymphokines.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Grammer, T. B., Fuchs, D., Boehm, B. O., Winkelmann, B. R., Maerz, W. (2009). Neopterin as a Predictor of Total and Cardiovascular Mortality in Individuals Undergoing Angiography in the Ludwigshafen Risk and Cardiovascular Health Study. Clin. Chem. 55: 1135-1146 [Abstract] [Full Text]
Adachi, T, Naruko, T, Itoh, A, Komatsu, R, Abe, Y, Shirai, N, Yamashita, H, Ehara, S, Nakagawa, M, Kitabayashi, C, Ikura, Y, Ohsawa, M, Yoshiyama, M, Haze, K, Ueda, M (2007). Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions. Heart 93: 1537-1541 [Abstract] [Full Text]
Punjabi, N. M., Beamer, B. A., Jain, A., Spencer, M. E., Fedarko, N. (2007). Elevated Levels of Neopterin in Sleep-Disordered Breathing. Chest 132: 1124-1130 [Abstract] [Full Text]
Minami, A., Tsuboi, I., Harada, T., Fukumoto, T., Hiramoto, M., Koshinaga, M., Hirabayashi, Y., Kanno, J., Inoue, T., Aizawa, S. (2007). Inflammatory Biomarker, Neopterin, Suppresses B Lymphopoiesis for Possible Facilitation of Granulocyte Responses, Which Is Severely Altered in Age-Related Stromal-Cell-Impaired Mice, SCI/SAM. Exp. Biol. Med. 232: 134-145 [Abstract] [Full Text]
Barutcuoglu, B., Bozdemir, A. E., Dereli, D., Parildar, Z., Mutaf, M. I., Ozmen, D., Bayindir, O. (2006). Increased Serum Neopterin Levels in Women with Polycystic Ovary Syndrome. Annals of Clinical & Laboratory Science 36: 267-272 [Abstract] [Full Text]
Sghiri, R., Feinberg, J., Thabet, F., Dellagi, K., Boukadida, J., Ben Abdelaziz, A., Casanova, J. L., Barbouche, M. R. (2005). Gamma Interferon Is Dispensable for Neopterin Production In Vivo. CVI 12: 1437-1441 [Abstract] [Full Text]
Stratigos, A. J., Malanos, D., Touloumi, G., Antoniou, A., Potouridou, I., Polydorou, D., Katsambas, A. D., Whitby, D., Mueller, N., Stratigos, J. D., Hatzakis, A. (2005). Association of Clinical Progression in Classic Kaposi's Sarcoma With Reduction of Peripheral B Lymphocytes and Partial Increase in Serum Immune Activation Markers. Arch Dermatol 141: 1421-1426 [Abstract] [Full Text]
Hainz, U., Obexer, P., Winkler, C., Sedlmayr, P., Takikawa, O., Greinix, H., Lawitschka, A., Putschger, U., Fuchs, D., Ladisch, S., Heitger, A. (2005). Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation. Blood 105: 4127-4134 [Abstract] [Full Text]
Avanzas, P., Arroyo-Espliguero, R., Quiles, J., Roy, D., Kaski, J. C. (2005). Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 26: 457-463 [Abstract] [Full Text]
Vollmer, T L, Phillips, J T, Goodman, A D, Agius, M A, Libonati, M A, Giacchino, J L, Grundy, J S (2004). An open-label safety and drug interaction study of natalizumab (AntegrenTM) in combination with interferon-beta (Avonex(R)) in patients with multiple sclerosis. Mult Scler 10: 511-520 [Abstract]
Zouridakis, E., Avanzas, P., Arroyo-Espliguero, R., Fredericks, S., Kaski, J. C. (2004). Markers of Inflammation and Rapid Coronary Artery Disease Progression in Patients With Stable Angina Pectoris. Circulation 110: 1747-1753 [Abstract] [Full Text]
Avanzas, P, Arroyo-Espliguero, R, Cosin-Sales, J, Aldama, G, Pizzi, C, Quiles, J, Kaski, J C (2004). Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 90: 847-852 [Abstract] [Full Text]
Kaski, J. C., Avanzas, P., Arroyo-Espliguero, R. (2003). Neopterin--a forgotten biomarker. J Am Coll Cardiol 42: 1142-1143 [Full Text]
Wirleitner, B., Reider, D., Ebner, S., Bock, G., Widner, B., Jaeger, M., Schennach, H., Romani, N., Fuchs, D. (2002). Monocyte-derived dendritic cells release neopterin. J. Leukoc. Biol. 72: 1148-1153 [Abstract] [Full Text]
Motzer, R. J., Rakhit, A., Thompson, J., Gurney, H., Selby, P., Figlin, R., Negrier, S., Ernst, S., Siebels, M., Ginsberg, M., Rittweger, K., Hooftman, L. (2002). Phase II trial of branched peginterferon-{alpha} 2a (40 kDa) for patients with advanced renal cell carcinoma. Ann Oncol 13: 1799-1805 [Abstract] [Full Text]
Schennach, H., Murr, C., Larcher, C., Streif, W., Pastner, E., Zaknun, D., Schonitzer, D., Fuchs, D. (2002). Neopterin Concentrations in Cord Blood: A Single-Cohort Study of Paired Samples from 541 Pregnant Women and Their Newborns. Clin. Chem. 48: 2059-2061 [Full Text]
Tarpey, M. M. (2002). Sepiapterin Treatment in Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 22: 1519-1521 [Full Text]
Auer, J., Berent, R., Lassnig, E., Weber, T., Eber, B. (2002). Prognostic significance of immune activation after acute coronary syndromes. J Am Coll Cardiol 39: 1878-1878 [Full Text]
Schennach, H., Murr, C., Gachter, E., Mayersbach, P., Schonitzer, D., Fuchs, D. (2002). Factors Influencing Serum Neopterin Concentrations in a Population of Blood Donors. Clin. Chem. 48: 643-645 [Full Text]
Tilg, H, van Montfrans, C, van den Ende, A, Kaser, A, van Deventer, S J H, Schreiber, S, Gregor, M, Ludwiczek, O, Rutgeerts, P, Gasche, C, Koningsberger, J C, Abreu, L, Kuhn, I, Cohard, M, LeBeaut, A, Grint, P, Weiss, G (2002). Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon {gamma}. Gut 50: 191-195 [Abstract] [Full Text]
Motzer, R. J., Rakhit, A., Ginsberg, M., Rittweger, K., Vuky, J., Yu, R., Fettner, S., Hooftman, L. (2001). Phase I Trial of 40-kd Branched Pegylated Interferon Alfa-2a for Patients With Advanced Renal Cell Carcinoma. JCO 19: 1312-1319 [Abstract] [Full Text]
Caforio, A. L.P., Goldman, J. H., Baig, M. K., Mahon, N. J., Haven, A. J., Souberbielle, B. E., Holt, D. W., Dalgleish, A. G., McKenna, W. J. (2001). Elevated serum levels of soluble interleukin-2 receptor, neopterin and {beta}-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis. Eur J Heart Fail 3: 155-163 [Abstract] [Full Text]
Palmer, H E, Giovannoni, G, Stanford, M R, Wallace, G R, Graham, E M (2001). Urinary neopterin in idiopathic retinal vasculitis. Br J Ophthalmol 85: 30-33 [Abstract] [Full Text]
Prommegger, R., Widner, B., Murr, C., Unger, A., Fuchs, D., Salzer, G. M. (2000). Neopterin: a prognostic variable in operations for lung cancer. Ann. Thorac. Surg. 70: 1861-1864 [Abstract] [Full Text]
Amirayan-Chevillard, N., Tissot-Dupont, H., Obadia, Y., Gallais, H., Mege, J.-L., Capo, C. (2000). Highly Active Antiretroviral Therapy (HAART) and Circulating Markers of Immune Activation: Specific Effect of HAART on Neopterin. CVI 7: 832-834 [Abstract] [Full Text]
Gottsater, A., Anwaar, I., Eriksson, K.-F., Mattiasson, I., Lindgarde, F., Gottsater, A. (2000). Homocysteine Is Related to Neopterin and Endothelin-1 in Plasma of Subjects with Disturbed Glucose Metabolism and Reference Subjects. ANGIOLOGY 51: 489-497 [Abstract]
Garcia-Moll, X., Coccolo, F., Cole, D., Kaski, J. C. (2000). Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol 35: 956-962 [Abstract] [Full Text]
Garcia-Moll, X, Cole, D, Zouridakis, E, Kaski, J C (2000). Increased serum neopterin: a marker of coronary artery disease activity in women. Heart 83: 346-350 [Abstract] [Full Text]
Hyland, K., Arnold, L. A. (1999). Value of Lumbar Puncture in the Diagnosis of Genetic Metabolic Encephalopathies. J Child Neurol 14: S9-S15 [Abstract]
Erren, M., Reinecke, H., Junker, R., Fobker, M., Schulte, H., Schurek, J. O., Kropf, J., Kerber, S., Breithardt, G., Assmann, G., Cullen, P. (1999). Systemic Inflammatory Parameters in Patients With Atherosclerosis of the Coronary and Peripheral Arteries. Arterioscler. Thromb. Vasc. Bio. 19: 2355-2363 [Abstract] [Full Text]
Vasquez-Vivar, J., Hogg, N., Martasek, P., Karoui, H., Pritchard, K. A. Jr., Kalyanaraman, B. (1999). Tetrahydrobiopterin-dependent Inhibition of Superoxide Generation from Neuronal Nitric Oxide Synthase. J. Biol. Chem. 274: 26736-26742 [Abstract] [Full Text]
Aziz, N., Nishanian, P., Mitsuyasu, R., Detels, R., Fahey, J. L. (1999). Variables That Affect Assays for Plasma Cytokines and Soluble Activation Markers. CVI 6: 89-95 [Abstract] [Full Text]
Anwaar, I., Gottsater, A., Lindgarde, F., Mattiasson, I. (1999). Increasing Plasma Neopterin and Persistent Plasma Endothelin During Follow-up After Acute Cerebral Ischemia. ANGIOLOGY 50: 1-8 [Abstract]
Aziz, N., Nishanian, P., Fahey, J. L. (1998). Levels of Cytokines and Immune Activation Markers in Plasma in Human Immunodeficiency Virus Infection: Quality Control Procedures. CVI 5: 755-761 [Abstract] [Full Text]
Fahey, J. L. (1998). Cytokines, Plasma Immune Activation Markers, and Clinically Relevant Surrogate Markers in Human Immunodeficiency Virus Infection. CVI 5: 597-603 [Full Text]
Nishanian, P., Aziz, N., Chung, J., Detels, R., Fahey, J. L. (1998). Oral Fluids as an Alternative to Serum for Measurement of Markers of Immune Activation. CVI 5: 507-512 [Abstract] [Full Text]
Petereit, H., Bamborschke, S., Esse, A., Heiss, W. (1997). Interferon gamma producing blood lymphocytes are decreased by interferon beta therapy in patients with multiple sclerosis. Mult Scler 3: 180-183 [Abstract]
(1996). Meeting Report and Proceedings: Multiple Sclerosis Society of Great Britain and Northern Ireland. Mult Scler 2: 1-55
Samsonov, M. Y, Tilz, G. P, Egorova, O., Reibnegger, G., Balabanova, R. M, Nassonov, E. L, Nassonova, V. A, Wachter, H., Fuchs, D. (1995). Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 4: 29-32 [Abstract]
Komori, H., Matsuishi, T., Yamada, S., Ichikawa, K., Amamoto, M., Yamashita, F. (1994). Elevated Biopterin and Homovanillic Acid Levels in Cerebrospinal Fluid From Children With Aseptic Meningitis. J Child Neurol 9: 22-25 [Abstract]
Bansil, S., Mithen, F. A., Singhal, B. S., Cook, S. D., Rohowsky-Kochan, C. (1992). Elevated Neopterin Levels in Guillain-Barre Syndrome: Further Evidence of Immune Activation. Arch Neurol 49: 1277-1280 [Abstract]
(1992). Diagnostic and Therapeutic Technology Assessment (DATTA). JAMA 267: 2948-2952
Richtsmeier, W. J., Koch, W. M., McGuire, W. P., Poole, M. E., Chang, E. H. (1990). Phase I-II Study of Advanced Head and Neck Squamous Cell Carcinoma Patients Treated With Recombinant Human Interferon Gamma. Arch Otolaryngol Head Neck Surg 116: 1271-1277 [Abstract]
FUCHS, D., REIBNEGGER, G., WACHTER, H., JAEGER, H., POPESCU, M., KABOTH, W. (1987). Neopterin Levels correlating with the Walter Reed Staging Classification in Human Immunodeficiency Virus (HIV) Infection. ANN INTERN MED 107: 784-785 [Abstract]